455 results on '"Bourdin, Arnaud"'
Search Results
2. Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.
3. MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab
4. Sacubitril/valsartan has an underestimated impact on the right ventricle in patients with sleep-disordered breathing, especially central sleep apnoea syndrome
5. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma
6. Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma
7. Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics
8. Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
9. Definition, Phenotyping of Severe Asthma, Including Cluster Analysis
10. Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
11. Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
12. Mepolizumab Reduces Systemic Corticosteroid Use in Chronic Rhinosinusitis With Nasal Polyps
13. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
14. Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: The NAVIGATOR study
15. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
16. Definition, Phenotyping of Severe Asthma, Including Cluster Analysis
17. Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
18. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version
19. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
20. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
21. Anti-IL-4R versus Anti-IL-5/5R after Anti-IL-5/5R failure in asthma: an emulated target trial
22. VJBM-2023-0014 Final
23. Hospitalizations for Chronic Obstructive Pulmonary Disease Exacerbation During COVID-19
24. Altered skeletal muscle function and beneficial effects of exercise training in a rat model of induced pulmonary emphysema
25. The HHIP gene: from a candidate to an established participant in COPD susceptibility
26. Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline
27. Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study
28. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension
29. Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases
30. Position paper of the French Society of Respiratory Diseases regarding pharmacological treatment optimization for stable COPD in 2021
31. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial
32. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
33. iPSCs derived from infertile men carrying complex genetic abnormalities can generate primordial germ-like cells
34. Artificial intelligence to differentiate asthma from COPD in medico-administrative databases
35. Did COVID-19 impact Positive Airway Pressure adherence in 2020? A cross-sectional study of 8477 patients with sleep apnea
36. CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles
37. Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion
38. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
39. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
40. Transition of care from adolescence to early adulthood in severe asthmatic patients treated with omalizumab in real life.
41. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
42. Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years
43. Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis
44. Severe asthma care trajectories: the French RAMSES cohort
45. Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
46. Longitudinal patterns of intermittent oral corticosteroid use for asthma in the UK
47. Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
48. Long-Term Efficacy Of Dupilumab In Patients With Moderate-To-Severe Type 2 Asthma Stratified By Baseline Characteristics During The 96-Week TRAVERSE Study
49. Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study
50. CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.